Uniphar (LON:UPR) Shares Up 2.1% - Time to Buy?

Key Points

• Shares up 2.1% — Uniphar traded as high as GBX 350 and last at GBX 340 on Wednesday, but volume was just 14,572 shares, an 84% decline from the average session volume.
• The stock has a market cap of £882.6m and a P/E of 17.44, but liquidity is weak (quick ratio 0.60, current ratio 0.99) and it carries very high leverage with a debt-to-equity of 159.99.
• Uniphar is a Dublin‑headquartered diversified healthcare services group serving 200+ pharmaceutical and medtech customers across Commercial & Clinical, Product Access and Supply Chain & Retail in Ireland, the UK and the Benelux.

Shares of Uniphar plc (LON:UPR - ) shot up 2.1% during trading on Wednesday . The company traded as high as GBX 350 and last traded at GBX 340. 14,572 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 93,432 shares. The stock had previously closed at GBX 333.

Uniphar Trading Up 2.1%

The stock has a market cap of £882.55 million, a price-to-earnings ratio of 17.44 and a beta of 1.19. The company has a quick ratio of 0.60, a current ratio of 0.99 and a debt-to-equity ratio of 159.99. The business's 50 day simple moving average is GBX 341.58 and its 200 day simple moving average is GBX 329.93.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.